Muscle pain perception and sympathetic nerve activity to exercise during opioid modulation
- 1 November 2000
- journal article
- clinical trial
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 279 (5) , R1565-R1573
Abstract
The purpose of this experiment was to examine the effects of the endogenous opioid system on forearm muscle pain and muscle sympathetic nerve activity (MSNA) during dynamic fatiguing exercise. Twelve college-age men (24 ± 4 yr) performed graded (1-min stages; 30 contractions/min) handgrip to fatigue 1 h after the ingestion of either 60 mg codeine, 50 mg naltrexone, or placebo. Pain (0–10 scale) and exertion (0–10 and 6–20 scales) intensities were measured during the last 15 s of each minute of exercise and every 15 s during recovery. MSNA was measured continuously from the peroneal nerve in the left leg. Pain threshold occurred earlier [1.8 ± 1, 2.2 ± 1, 2.2 ± 1 J: codeine, naltrexone, and placebo, respectively] and was associated with a lower rating of perceived exertion (RPE) (2.7 ± 2, 3.6 ± 2, 3.8 ± 2: codeine, naltrexone, and placebo, respectively) in the codeine condition compared with either the naltrexone or placebo conditions. There were no main effects (i.e., drugs) or interaction (i.e., drugs × time) for either forearm muscle pain or RPE during exercise [pain: F (2, 22) = 0.69, P = 0.51]. There was no effect of drug on MSNA, heart rate, or blood pressure during baseline, exercise, or recovery. Peak exercise MSNA responses were 21 ± 1, 21 ± 2.0, and 21 ± 2.0 bursts/30 s for codeine, naltrexone, and placebo conditions, respectively. Peak mean arterial pressure responses were 135 ± 4, 131 ± 3, and 132 ± 4 mmHg for codeine, naltrexone, and placebo conditions, respectively. It is concluded that neither 60 mg codeine nor 50 mg naltrexone has an effect on forearm muscle pain, exertion, or MSNA during high- intensity handgrip to fatigue.Keywords
This publication has 26 references indexed in Scilit:
- The pharmacogenetics of codeine hypoalgesiaPharmacogenetics, 1995
- Human Pharmacokinetic Study of Immediate-Release (Codeine Phosphate) and Sustained-Release (Codeine Contin) CodeineThe Journal of Clinical Pharmacology, 1994
- Integrated activity of cardiovascular and pain regulatory systems: Role in adaptive behavioural responsesProgress in Neurobiology, 1993
- Changes in ??-Endorphin Levels in Response to Aerobic and Anaerobic ExerciseSports Medicine, 1992
- The short-form McGill pain questionnairePain, 1987
- Differential control of heart rate and sympathetic nerve activity during dynamic exercise. Insight from intraneural recordings in humans.Journal of Clinical Investigation, 1987
- Interactions between cardiovascular and pain regulatory systemsNeuroscience & Biobehavioral Reviews, 1984
- A modified submaximal effort tourniquet test for evaluation of analgesics in healthy volunteersPain, 1984
- The Exercise Pressor Reflex: Its Cardiovascular Effects, Afferent Mechanisms, and Central PathwaysAnnual Review of Physiology, 1983
- Subjective Aspects of Physical and Mental LoadErgonomics, 1978